{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:15:05Z","timestamp":1783098905386,"version":"3.54.6"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00210-021-02147-6","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T09:02:56Z","timestamp":1630746176000},"page":"2013-2021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Covid-19 and development of heart failure: mystery and truth"],"prefix":"10.1007","volume":"394","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1890-6324","authenticated-orcid":false,"given":"Hope","family":"Onohuean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safaa","family":"Qusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eida M.","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,4]]},"reference":[{"key":"2147_CR1","doi-asserted-by":"publisher","unstructured":"Adinolfi LE, Zampino R, Restivo L, et al. (2014) Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms. World J Gastroenterolhttps:\/\/doi.org\/10.3748\/wjg.v20.i13.3410","DOI":"10.3748\/wjg.v20.i13.3410"},{"key":"2147_CR2","doi-asserted-by":"publisher","unstructured":"Al-kuraishy H, Al-Gareeb A, Al-Buhadilly A (2018) Rosuvastatin improves vaspin serum levels in obese patients with acute coronary syndrome. Diseaseshttps:\/\/doi.org\/10.3390\/diseases6010009","DOI":"10.3390\/diseases6010009"},{"key":"2147_CR3","doi-asserted-by":"publisher","unstructured":"Al-Kuraishy H, Hussien N, Al-Naimi M, et al. (2020) Is ivermectin-azithromycin combination the next step for COVID-19? Biomed Biotechnol Res Jhttps:\/\/doi.org\/10.4103\/bbrj.bbrj_109_20","DOI":"10.4103\/bbrj.bbrj_109_20"},{"key":"2147_CR4","doi-asserted-by":"publisher","unstructured":"Al-Kuraishy HM, Al-Gareeb AI (2017) Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction: role of statins. J Lab Physicianshttps:\/\/doi.org\/10.4103\/0974-2727.208263","DOI":"10.4103\/0974-2727.208263"},{"key":"2147_CR5","doi-asserted-by":"publisher","unstructured":"Al-Kuraishy HM, Al-Gareeb AI (2016) Potential effects of pomegranate on lipid peroxidation and pro-inflammatory changes in daunorubicin-induced cardiotoxicity in rats. Int J Prev Medhttps:\/\/doi.org\/10.4103\/2008-7802.184314","DOI":"10.4103\/2008-7802.184314"},{"key":"2147_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.642181","author":"HM Al-kuraishy","year":"2021","unstructured":"Al-kuraishy HM, Al-Gareeb AI, Abdullah SM et al (2021) Case report: Hyperbilirubinemia in Gilbert syndrome attenuates Covid-19-induced metabolic disturbances. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2021.642181","journal-title":"Front Cardiovasc Med"},{"key":"2147_CR7","doi-asserted-by":"publisher","unstructured":"Al-kuraishy HM, Al-Gareeb AI, Alblihed M et al (2021) COVID-19 and risk of acute ischemic stroke and acute lung injury in patients with type II diabetes mellitus: the anti-inflammatory role of metformin. Front Med. https:\/\/doi.org\/10.3389\/fmed.2021.644295","DOI":"10.3389\/fmed.2021.644295"},{"key":"2147_CR8","doi-asserted-by":"crossref","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Almulaiky YQ, Cruz-Martins N, & Batiha GES (2021) Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity. European journal of pharmacology, 174196","DOI":"10.1016\/j.ejphar.2021.174196"},{"key":"2147_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-021-04232-z","author":"HM Al-kuraishy","year":"2021","unstructured":"Al-kuraishy HM, Al-Gareeb AI, Alzahrani KJ et al (2021) The potential role of neopterin in Covid-19: a new perspective. Mol Cell Biochem. https:\/\/doi.org\/10.1007\/s11010-021-04232-z","journal-title":"Mol Cell Biochem"},{"key":"2147_CR10","doi-asserted-by":"crossref","unstructured":"Al-kuraishy HM, Al-Gareeb AI, Faidah H, et al. (2021e) The looming effects of estrogen in Covid-19: a rocky rollout. Front Nutr","DOI":"10.3389\/fnut.2021.649128"},{"key":"2147_CR11","doi-asserted-by":"crossref","unstructured":"Amarelle L, Lecuona E (2018) The antiviral effects of Na,K-ATPase inhibition: a minireview. Int J Mol Sci","DOI":"10.3390\/ijms19082154"},{"key":"2147_CR12","doi-asserted-by":"publisher","unstructured":"Amirshahrokhi K, Khalili AR (2016) Carvedilol attenuates paraquat-induced lung injury by inhibition of proinflammatory cytokines, chemokine MCP-1, NF-\u03baB activation and oxidative stress mediators. Cytokine https:\/\/doi.org\/10.1016\/j.cyto.2016.09.004","DOI":"10.1016\/j.cyto.2016.09.004"},{"key":"2147_CR13","unstructured":"Ashraf H, Norouzi P, Jafari S (2011) Hodgkin\u2019s disease with hyperferritinemia, hepatic and heart failure. Govaresh"},{"key":"2147_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biom11050653","author":"SO Asiedu","year":"2021","unstructured":"Asiedu SO, Kwofie SK, Broni E, Wilson MD (2021) Computational identification of potential anti-inflammatory natural compounds targeting the p38 mitogen-activated protein kinase (Mapk): implications for covid-19-induced cytokine storm. Biomolecules. https:\/\/doi.org\/10.3390\/biom11050653","journal-title":"Biomolecules"},{"key":"2147_CR15","doi-asserted-by":"publisher","unstructured":"Athanasios T, Psychos C, Domenikos S (2020) Communication: Novel drug combination doxycycline-melatonin-digoxin(D-M-D) for possible Covid-19 treatment. J Mod Med Chem https:\/\/doi.org\/10.12970\/2308-8044.2020.08.01","DOI":"10.12970\/2308-8044.2020.08.01"},{"key":"2147_CR16","doi-asserted-by":"crossref","unstructured":"Bader F, Manla Y, Atallah B, Starling RC (2021) Heart failure and COVID-19. Heart Fail. Rev","DOI":"10.1007\/s10741-020-10008-2"},{"key":"2147_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/eurjcn\/zvab060.041","author":"H Badreldin","year":"2021","unstructured":"Badreldin H, Hafidh D, Bin Saleh D et al (2021) Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID19): a multicenter cohort study. Eur J Cardiovasc Nurs. https:\/\/doi.org\/10.1093\/eurjcn\/zvab060.041","journal-title":"Eur J Cardiovasc Nurs"},{"key":"2147_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.048360","author":"Z Belhadjer","year":"2020","unstructured":"Belhadjer Z, M\u00e9ot M, Bajolle F et al (2020) Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.048360","journal-title":"Circulation"},{"key":"2147_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2020.11.003","author":"AS Bhatt","year":"2021","unstructured":"Bhatt AS, Jering KS, Vaduganathan M et al (2021) Clinical outcomes in patients with heart failure hospitalized with COVID-19. JACC Hear Fail. https:\/\/doi.org\/10.1016\/j.jchf.2020.11.003","journal-title":"JACC Hear Fail"},{"key":"2147_CR20","doi-asserted-by":"crossref","unstructured":"Bozkurt B, Kovacs R, Harrington B (2020) Joint HFSA\/ACC\/AHA statement addresses concerns re: using RAAS antagonists in COVID-19. J Card Fail","DOI":"10.1016\/j.cardfail.2020.04.013"},{"key":"2147_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.03274-14","author":"C Burkard","year":"2015","unstructured":"Burkard C, Verheije MH, Haagmans BL et al (2015) ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells. J Virol. https:\/\/doi.org\/10.1128\/jvi.03274-14","journal-title":"J Virol"},{"key":"2147_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.151","author":"AA Butt","year":"2011","unstructured":"Butt AA, Chang CC, Kuller L et al (2011) Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease. Arch Intern Med. https:\/\/doi.org\/10.1001\/archinternmed.2011.151","journal-title":"Arch Intern Med"},{"key":"2147_CR23","doi-asserted-by":"crossref","unstructured":"Butts B, Gary RA, Dunbar SB, Butler J (2015) The importance of NLRP3 inflammasome in heart failure. J Card Fail","DOI":"10.1016\/j.cardfail.2015.04.014"},{"key":"2147_CR24","unstructured":"Can B, \u00d6z S, Mu\u015fmul A, et al (2018) Effects of conivaptan and mannitol on serum cytokine levels (TNF-\u03b1, IL-15 and IL-35) following bilateral carotid artery occlusion. undefined"},{"key":"2147_CR25","doi-asserted-by":"crossref","unstructured":"Chen C, Zhou Y, Wang DW (2020a) SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz","DOI":"10.1007\/s00059-020-04909-z"},{"key":"2147_CR26","doi-asserted-by":"crossref","unstructured":"Chen L, Hao G (2020) The role of angiotensin-converting enzyme 2 in coronaviruses\/influenza viruses and cardiovascular disease. Cardiovasc Res","DOI":"10.2139\/ssrn.3537961"},{"key":"2147_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/CVR\/CVAA078","author":"L Chen","year":"2020","unstructured":"Chen L, Li X, Chen M et al (2020) The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. https:\/\/doi.org\/10.1093\/CVR\/CVAA078","journal-title":"Cardiovasc Res"},{"key":"2147_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72879-7","author":"J Cho","year":"2020","unstructured":"Cho J, Lee YJ, Kim JH et al (2020) Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-020-72879-7","journal-title":"Sci Rep"},{"key":"2147_CR29","doi-asserted-by":"publisher","DOI":"10.3138\/canlivj-2020-0007","author":"SE Congly","year":"2020","unstructured":"Congly SE, Sadler MD, Abraldes JG et al (2020) Practical management of esophageal varices in the context of SARS-CoV-2 (COVID-19): the Alberta protocol. Can Liver J. https:\/\/doi.org\/10.3138\/canlivj-2020-0007","journal-title":"Can Liver J"},{"key":"2147_CR30","unstructured":"Dumanl\u0131 GY, Dilken O, \u00dcrkmez S (2020) Use of spironolactone in SARS-CoV-2 ARDS patients. Turk J Anaesthesiol Reanim"},{"key":"2147_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25285","author":"AR Falsey","year":"2019","unstructured":"Falsey AR, Walsh EE, Esser MT et al (2019) Respiratory syncytial virus\u2013associated illness in adults with advanced chronic obstructive pulmonary disease and\/or congestive heart failure. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.25285","journal-title":"J Med Virol"},{"key":"2147_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172745","author":"N Farr\u00e9","year":"2017","unstructured":"Farr\u00e9 N, Vela E, Cl\u00e8ries M et al (2017) Real world heart failure epidemiology and outcome: a population-based analysis of 88,195 patients. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0172745","journal-title":"PLoS One"},{"key":"2147_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1802346","author":"S Gul","year":"2020","unstructured":"Gul S, Ozcan O, Asar S et al (2020) In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1802346","journal-title":"J Biomol Struct Dyn"},{"key":"2147_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1770129","author":"H Han","year":"2020","unstructured":"Han H, Ma Q, Li C et al (2020) Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. https:\/\/doi.org\/10.1080\/22221751.2020.1770129","journal-title":"Emerg Microbes Infect"},{"key":"2147_CR35","doi-asserted-by":"crossref","unstructured":"Hemmat N, Asadzadeh Z, Ahangar NK, et al (2021) The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV. Arch Virol","DOI":"10.1007\/s00705-021-04958-7"},{"key":"2147_CR36","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.22.20137273","author":"P Horby","year":"2020","unstructured":"Horby P, Lim WS, Emberson J et al (2020) Effect of dexamethasone in hospitalized patients with COVID-19\u2013preliminary report. N Engl J Med. https:\/\/doi.org\/10.1101\/2020.06.22.20137273","journal-title":"N Engl J Med"},{"key":"2147_CR37","doi-asserted-by":"crossref","unstructured":"Hu YF, Cheng WH, Hung Y, et al. (2020) Management of atrial fibrillation in COVID-19 pandemic. Circ J","DOI":"10.22541\/au.159050420.04320654"},{"key":"2147_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-008-7249-9","author":"K Ihenetu","year":"2008","unstructured":"Ihenetu K, Espinosa R, De Leon R et al (2008) Digoxin and digoxin-like immunoreactive factors (DLIF) modulate the release of pro-inflammatory cytokines. Inflamm Res. https:\/\/doi.org\/10.1007\/s00011-008-7249-9","journal-title":"Inflamm Res"},{"key":"2147_CR39","doi-asserted-by":"crossref","unstructured":"Imazio M, Klingel K, Kindermann I, et al. (2020) COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? Heart","DOI":"10.1136\/heartjnl-2020-317186"},{"key":"2147_CR40","doi-asserted-by":"publisher","unstructured":"Kartik Pandurang J, Pankaj V J (2020) Ivabradine versus carvedilol in the management of palpitation with sinus tachycardia among recovered COVID-19 patients. J Cardiol Cardiovasc Med https:\/\/doi.org\/10.29328\/journal.jccm.1001107","DOI":"10.29328\/journal.jccm.1001107"},{"key":"2147_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000187500.24964.7A","author":"S Keidar","year":"2005","unstructured":"Keidar S, Gamliel-Lazarovich A, Kaplan M et al (2005) Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients. Circ Res. https:\/\/doi.org\/10.1161\/01.RES.0000187500.24964.7A","journal-title":"Circ Res"},{"key":"2147_CR42","doi-asserted-by":"crossref","unstructured":"Kotfis K, Lechowicz K, Dro\u017cd\u017cal S, et al (2021) COVID-19\u2014the potential beneficial therapeutic effects of spironolactone during SARS-CoV-2 infection. Pharmaceuticals","DOI":"10.3390\/ph14010071"},{"key":"2147_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2007.00531.x","author":"US Kristoffersen","year":"2008","unstructured":"Kristoffersen US, Lebech AM, Gerstoft J et al (2008) Right and left cardiac function in HIV-infected patients investigated using radionuclide ventriculography and brain natriuretic peptide: a 5-year follow-up study. HIV Med. https:\/\/doi.org\/10.1111\/j.1468-1293.2007.00531.x","journal-title":"HIV Med"},{"key":"2147_CR44","unstructured":"Kurum T, Tatli E, Yuksel M (2007) Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy. Texas Hear Inst J"},{"key":"2147_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2015.03.017","author":"J Lee","year":"2015","unstructured":"Lee J, Baek S, Lee J et al (2015) Digoxin ameliorates autoimmune arthritis via suppression of Th17 differentiation. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2015.03.017","journal-title":"Int Immunopharmacol"},{"key":"2147_CR46","unstructured":"Liang J, Huang B, Yuan G, et al (2017) Stretch-activated channel Piezo1 is up-regulated in failure heart and cardiomyocyte stimulated by Angii. Am J Transl Res"},{"key":"2147_CR47","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-17-1118","author":"MS Lin","year":"2018","unstructured":"Lin MS, Chung CM, Chang ML et al (2018) The unraveled link between antiviral therapy and heart failure hospitalization in chronic hepatitis c virus infection\u2014a nationwide cohort study. Circ J. https:\/\/doi.org\/10.1253\/circj.CJ-17-1118","journal-title":"Circ J"},{"key":"2147_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.12.060","author":"RD Lopes","year":"2018","unstructured":"Lopes RD, Rordorf R, De Ferrari GM et al (2018) Digoxin and mortality in patients with atrial fibrillation. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2017.12.060","journal-title":"J Am Coll Cardiol"},{"key":"2147_CR49","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00331.2008","author":"F Lovren","year":"2008","unstructured":"Lovren F, Pan Y, Quan A et al (2008) Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am J Physiol - Heart Circ Physiol. https:\/\/doi.org\/10.1152\/ajpheart.00331.2008","journal-title":"Am J Physiol - Heart Circ Physiol"},{"key":"2147_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2016.05.013","author":"Y Lu","year":"2016","unstructured":"Lu Y, Hou H, Wang F et al (2016) ATP1B3: a virus-induced host factor against EV71 replication by up-regulating the production of type-I interferons. Virology. https:\/\/doi.org\/10.1016\/j.virol.2016.05.013","journal-title":"Virology"},{"key":"2147_CR51","doi-asserted-by":"crossref","unstructured":"Lugnier C, Al-Kuraishy HM, Rousseau E (2021) PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking. Biochem Pharmacol","DOI":"10.1016\/j.bcp.2021.114431"},{"key":"2147_CR52","doi-asserted-by":"crossref","unstructured":"M. Al-Kuraishy H, S. Al-Niemi M, R. Hussain N, et al (2020) The potential role of renin angiotensin system (RAS) and dipeptidyl peptidase-4 (DPP-4) in COVID-19: navigating the uncharted. In: Selected chapters from the renin-angiotensin system","DOI":"10.5772\/intechopen.92837"},{"key":"2147_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1482","author":"G Markousis-Mavrogenis","year":"2019","unstructured":"Markousis-Mavrogenis G, Tromp J, Ouwerkerk W et al (2019) The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.1482","journal-title":"Eur J Heart Fail"},{"key":"2147_CR54","doi-asserted-by":"crossref","unstructured":"Matsoukas J, Apostolopoulos V, Zulli A, et al (2021) From angiotensin II to cyclic peptides and angiotensin receptor blockers (Arbs): perspectives of arbs in covid-19 therapy. Molecules","DOI":"10.3390\/molecules26030618"},{"key":"2147_CR55","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.63.934","author":"A Matsumori","year":"1999","unstructured":"Matsumori A, Igata H, Ono K et al (1999) High doses of digitalis increase the myocardial production of proinflammatory cytokines and worsen myocardial injury in viral myocarditis: a possible mechanism of digitalis toxicity. Jpn Circ J. https:\/\/doi.org\/10.1253\/jcj.63.934","journal-title":"Jpn Circ J"},{"key":"2147_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2005.11.004","author":"A Matsumori","year":"2006","unstructured":"Matsumori A, Shimada T, Chapman NM et al (2006) Myocarditis and heart failure associated with hepatitis C virus infection. J Card Fail. https:\/\/doi.org\/10.1016\/j.cardfail.2005.11.004","journal-title":"J Card Fail"},{"key":"2147_CR57","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14556","author":"DN Meijles","year":"2020","unstructured":"Meijles DN, Cull JJ, Markou T et al (2020) Redox regulation of cardiac ASK1 (apoptosis signal-regulating kinase 1) controls p38-MAPK (mitogen-activated protein kinase) and orchestrates cardiac remodeling to hypertension. Hypertension. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14556","journal-title":"Hypertension"},{"key":"2147_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/life11080734","author":"M Moubarak","year":"2021","unstructured":"Moubarak M, Kasozi KI, Hetta HF et al (2021) The rise of SARS-CoV-2 variants and the role of convalescent plasma therapy for management of infections. Life. https:\/\/doi.org\/10.3390\/life11080734","journal-title":"Life"},{"key":"2147_CR59","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1310\/HCT1103-156","volume":"11","author":"Reinsch Nico","year":"2010","unstructured":"Nico Reinsch, Neuhaus Kathrin, Esser Stefan, Potthoff Anja, Hower Martin, Brockmeyer Norbert H, Raimund Erbel TN (2010) Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials 11:156\u2013162. https:\/\/doi.org\/10.1310\/HCT1103-156","journal-title":"HIV Clin Trials"},{"key":"2147_CR60","doi-asserted-by":"crossref","unstructured":"Noroozi R, Branicki W, Pyrc K, et al (2020) Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions. Cytokine","DOI":"10.1016\/j.cyto.2020.155143"},{"key":"2147_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2009.11.057","author":"M Ohtsuki","year":"2010","unstructured":"Ohtsuki M, Morimoto SI, Izawa H et al (2010) Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure. Int J Cardiol. https:\/\/doi.org\/10.1016\/j.ijcard.2009.11.057","journal-title":"Int J Cardiol"},{"key":"2147_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2009.02153.x","author":"GY Oudit","year":"2009","unstructured":"Oudit GY, Kassiri Z, Jiang C et al (2009) SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. https:\/\/doi.org\/10.1111\/j.1365-2362.2009.02153.x","journal-title":"Eur J Clin Invest"},{"key":"2147_CR63","doi-asserted-by":"publisher","unstructured":"Padmanabhan P, Desikan R, Dixit NM (2020) Targeting TMPRSS2 and cathepsin B\/L together may be synergistic against SARS-CoV-2 infection. ChemRxiv. https:\/\/doi.org\/10.26434\/chemrxiv.12213125.v2","DOI":"10.26434\/chemrxiv.12213125.v2"},{"key":"2147_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.10.011","author":"MS Panhwar","year":"2019","unstructured":"Panhwar MS, Kalra A, Gupta T et al (2019) Effect of influenza on outcomes in patients with heart failure. JACC Hear Fail. https:\/\/doi.org\/10.1016\/j.jchf.2018.10.011","journal-title":"JACC Hear Fail"},{"key":"2147_CR65","doi-asserted-by":"crossref","unstructured":"Patel AB, Verma A (2020) COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? JAMA - J Am Med Assoc","DOI":"10.1001\/jama.2020.4812"},{"key":"2147_CR66","doi-asserted-by":"crossref","unstructured":"Peng X, Wang Y, Xi X, et al. (2021) Promising therapy for heart failure in patients with severe COVID-19: calming the cytokine storm. Cardiovasc Drugs Ther","DOI":"10.1007\/s10557-020-07120-8"},{"key":"2147_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcaa081","author":"M Phelps","year":"2021","unstructured":"Phelps M, Christensen DM, Gerds T et al (2021) Cardiovascular comorbidities as predictors for severe COVID-19 infection or death. Eur Hear J - Qual Care Clin Outcomes. https:\/\/doi.org\/10.1093\/ehjqcco\/qcaa081","journal-title":"Eur Hear J - Qual Care Clin Outcomes"},{"key":"2147_CR68","doi-asserted-by":"publisher","unstructured":"Pollard BS, Blancol JC, Pollard JR (2020) Classical drug digitoxin inhibits influenza cytokine storm, with implications for Covid-19 therapy. In Vivo (Brooklyn). https:\/\/doi.org\/10.21873\/invivo.12221","DOI":"10.21873\/invivo.12221"},{"key":"2147_CR69","doi-asserted-by":"crossref","unstructured":"Reza N, DeFilippis EM, Jessup M (2020) Secondary impact of the COVID-19 pandemic on patients with heart failure. Circ Hear Fail","DOI":"10.1161\/CIRCHEARTFAILURE.120.007219"},{"key":"2147_CR70","doi-asserted-by":"crossref","unstructured":"Rossignol P, Hernandez AF, Solomon SD, Zannad F (2019) Heart failure drug treatment. Lancet","DOI":"10.1016\/S0140-6736(18)31808-7"},{"key":"2147_CR71","doi-asserted-by":"crossref","unstructured":"Saed Aldien A, Ganesan GS, Wahbeh F, et al (2021) Systemic inflammation may induce cardiac injury in COVID-19 patients including children and adolescents without underlying cardiovascular diseases: a systematic review. Cardiovasc. Revascularization Med.","DOI":"10.1016\/j.carrev.2021.04.007"},{"key":"2147_CR72","doi-asserted-by":"crossref","unstructured":"Sanchis-Gomar F, Lavie CJ, Perez-Quilis C, et al (2020) Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019. Mayo Clin Proc","DOI":"10.1016\/j.mayocp.2020.03.026"},{"key":"2147_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2021.01.030","author":"ML Servato","year":"2021","unstructured":"Servato ML, Valente FX, Garc\u00eda-Moreno LG et al (2021) Intraventricular conundrum in a SARS-CoV-2\u2013positive patient with elevated biomarkers of myocardial injury. JACC Case Rep. https:\/\/doi.org\/10.1016\/j.jaccas.2021.01.030","journal-title":"JACC Case Rep"},{"key":"2147_CR74","doi-asserted-by":"crossref","unstructured":"Siniorakis E, Arvanitakis S, Katsianis A, Elkouris M (2021) Atrial fibrillation and flutter in patients hospitalized for COVID-19: the challenging role of digoxin. J Cardiovasc Electrophysiol","DOI":"10.1111\/jce.14894"},{"key":"2147_CR75","doi-asserted-by":"crossref","unstructured":"Skayem C, Ayoub N (2020) Carvedilol and COVID-19: a potential role in reducing infectivity and infection severity of SARS-CoV-2. Am J Med Sci","DOI":"10.1016\/j.amjms.2020.05.030"},{"key":"2147_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-017-0044-1","author":"M Soto","year":"2017","unstructured":"Soto M, Bang SI, McCombs J, Rodgers KE (2017) Renin Angiotensin system-modifying therapies are associated with improved pulmonary health. Clin Diabetes Endocrinol. https:\/\/doi.org\/10.1186\/s40842-017-0044-1","journal-title":"Clin Diabetes Endocrinol"},{"key":"2147_CR77","doi-asserted-by":"crossref","unstructured":"Sun Y, Danser AHJ, Lu X (2017) (Pro)renin receptor as a therapeutic target for the treatment of cardiovascular diseases? Pharmacol Res","DOI":"10.1016\/j.phrs.2017.05.016"},{"key":"2147_CR78","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab026","author":"TA Taz","year":"2021","unstructured":"Taz TA, Ahmed K, Paul BK et al (2021) Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbab026","journal-title":"Brief Bioinform"},{"key":"2147_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2008.12.003","author":"JI Tsui","year":"2009","unstructured":"Tsui JI, Whooley MA, Monto A et al (2009) Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul Study. J Card Fail. https:\/\/doi.org\/10.1016\/j.cardfail.2008.12.003","journal-title":"J Card Fail"},{"key":"2147_CR80","doi-asserted-by":"crossref","unstructured":"Tyagi SC, Singh M (2021) Multi-organ damage by covid-19: congestive (cardio-pulmonary) heart failure, and blood-heart barrier leakage. Mol Cell Biochem","DOI":"10.1007\/s11010-021-04054-z"},{"key":"2147_CR81","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0065","author":"ET Ulug","year":"1996","unstructured":"Ulug ET, Garry RF, Bose HR (1996) Inhibition of Na+K+ATPase activity in membranes of Sindbis virus-infected chick cells. Virology. https:\/\/doi.org\/10.1006\/viro.1996.0065","journal-title":"Virology"},{"key":"2147_CR82","doi-asserted-by":"crossref","unstructured":"Vardeny O, Solomon SD (2019) Influenza and heart failure: a catchy comorbid combination. JACC Hear Fail","DOI":"10.1016\/j.jchf.2018.11.008"},{"key":"2147_CR83","doi-asserted-by":"crossref","unstructured":"VasanthiDharmalingam P, Karuppagounder V, Watanabe K, et al (2021) SARS\u2013CoV-2 mediated hyperferritinemia and cardiac arrest: preliminary insights. Drug Discov Today","DOI":"10.1016\/j.drudis.2021.01.014"},{"key":"2147_CR84","doi-asserted-by":"crossref","unstructured":"Wang Y, Tikellis C, Thomas MC, Golledge J (2013) Angiotensin converting enzyme 2 and atherosclerosis. Atherosclerosis","DOI":"10.1016\/j.atherosclerosis.2012.08.018"},{"key":"2147_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-021-02147-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-021-02147-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-021-02147-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T10:25:51Z","timestamp":1633083951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-021-02147-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,4]]},"references-count":85,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2147"],"URL":"https:\/\/doi.org\/10.1007\/s00210-021-02147-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,4]]},"assertion":[{"value":"7 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have read and agreed to the final copy of the finding as contained in the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}